BACKGROUND Leucocyte telomere length (LTL) shortening is associated with cardiovascular ischemic events and
To improve diagnosis and prevention, it is thus urgent to refine classic CVD risk scores and identify new biomarkers of atherosclerotic disease initiation and early progression.
Attrition of telomeric DNA is assumed to be a biomarker of aging and health status (3) . Because age is a crucial determinant of CVD (4), the possibility that telomere attrition might predict cardiovascular risk has awakened tremendous interest. Telomeres are capping deoxyribonucleic acid (DNA)-nucleoprotein complexes that protect the ends of all eukaryotic chromosomes from degradation, unwanted recombination, or fusion (5) . In most somatic cells, including leukocytes, telomeric DNA is shortened with every cell division throughout life from right after birth, in part due to inactivation of the telomere-elongating polymerase telomerase. When telomeric DNA becomes critically short, cells trigger an irreversible DNA damage response that leads to cellular senescence and, eventually, to apoptosis, thus compromising tissue repair capacity and function (6) . Although human leukocyte telomere length (LTL) is predominantly determined by inheritance, it can be influenced by stresses during pregnancy and exhibits high interindividual variability at the same age (7, 8) . Telomeric dysfunction and attrition can be caused by genetic mutations (9) or cardiovascular risk factors (e.g., inflammation, oxidative stress, lack of estrogens, insulin resistance, smoking, obesity, alcohol abuse, sedentary life-style, psychological stress) (10) (11) (12) .
Numerous epidemiological studies have investigated the relation between LTL and cardiovascular ischemic events, but the outcomes are often conflicting or too heterogeneous, as recently revealed in 2 independent meta-analyses (13, 14) . In their metaanalysis of 27 studies, D'Mello et al. (13) found a significant association between shortened LTL and myocardial infarction, type 2 diabetes mellitus, and stroke. In their meta-analysis of 24 studies, many overlapping those of D'Mello et al. (13) , Haycock et al. (14) also showed an inverse association between LTL and nonfatal myocardial infarction, coronary heart disease death, and coronary revascularization, but the association with cerebrovascular disease was less certain. Paradoxically, D'Mello et al. (13) did not find a significant association between LTL and coronary artery disease (a secondary outcome defined as angina and nonfatal ischemic heart disease), suggesting that LTL attrition is a marker of plaque rupture and associated ischemic events.
An interesting question is whether shortened LTL is a prognostic biomarker for the early identification of subjects at high risk of developing CVD before symptoms appear. Compared with the wealth of information available on short LTL and established CVD (e.g., myocardial infarction or stroke), few epidemiological studies have focused on possible associations between telomere length (TL) and subclinical (asymptomatic) atherosclerosis. The Asklepios cohort study is the largest reported to date (2,509 volunteers free from established CVD, approximately 35 to 55 years of age) (15) . The main conclusion of the Asklepios study was that shortened LTL is not a substantial determinant of preclinical atherosclerosis in either sex, and that the association between LTL and CVD cannot be explained by increased predisposition to atherosclerosis as a consequence of shorter inherited telomeres (15) . Atherosclerosis in the Asklepios study was assessed in carotid and femoral arteries by intimamedia thickness (IMT) and by vascular echography (absence/presence of plaque), but the potential association between LTL and plaque volume was not assessed. Moreover, to the best of our knowledge, the possible association between CVD and short telomere load has not yet been investigated, despite firm evidence showing that the accumulation of a few critically short telomeres in a cell can trigger cellular senescence (16) (17) (18) (19) (20) . Here, we performed a crosssectional study using high-throughput quantitative fluorescence in situ hybridization (HT-QFISH) (18) to quantify the percentage of short telomeres (%LTL <3 kb) and average LTL in a subset of 1, 459 healthy volunteers in the PESA cohort, and investigated the possible association of these parameters with plaque burden measured by 3-dimensional (3D) sonography in different vascular territories.
METHODS
STUDY DESIGN AND POPULATION. The PESA study rationale and design were described elsewhere (21). Values are n (%) or mean AE SD.
CASC ¼ coronary artery calcium score.
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Telomere Length and Subclinical Atherosclerosis confocal microscopy to detect telomeres labeled with a fluorescent peptide nucleic acid probe against telomeric repeats. All samples were measured in duplicate, and mean LTL and %LTL<3 kb were calculated for each sample. Previous studies have used <3 kb as the cutoff for "short telomeres" in humans (18, 25) .
The intra-assay coefficient of variation was 6.3%
for LTL and 10.5% for %LTL<3 kb. 
RESULTS
The baseline prevalence of subclinical atherosclerotic lesions in the 1,459 study participants is summarized in Table 1 . The %LTL<3 kb did not differ across plaque burden categories in men or women.
Sex-and age-adjusted associations between telomere parameters and CVD risk factors are shown in Table 3 . The only direct significant associations after these adjustments were between %LTL<3 kb and urinary isoprostanes and serum ox-LDL in men (p ¼ 0.007 and 0.008, respectively), and between %LTL<3 kb and serum ox-LDL in women (p ¼ 0.001).
Associations between telomeres and atherosclerosis burden in the femoral and carotid arteries were investigated in 3 regression models: unadjusted, adjusted for age (and sex in nonstratified models), and also adjusted for 8 additional CVD risk factors ( Table 4 ). The analysis considered plaque burden in these territories individually and in combination (total plaque burden). In the unadjusted model, LTL reached statistical significance as a determinant of femoral plaque and total plaque burden in men, and in the total sample. However, the association did not hold after adjustment for age and sex (Model 1) or additional CVD risk factors (Model 2).
For %LTL<3 kb, none of the regression models showed significant associations for men, women, or the total sample.
DISCUSSION
An association between short LTL and the occurrence of cardiovascular ischemic events has been described in several studies (13, 14, 29) ; however, information is still scarce on the relationship between LTL and subclinical atherosclerosis in subjects free from established CVD. The short telomere load correlates with the number of senescent cells (17) , suggesting that an association between CVD and the number of short telomeres might be better than average LTL at predicting aging and associated atherosclerosis. PESA participants and performing a more extensive CVD ¼ cardiovascular disease; other abbreviations as in Table 2 .
Fernández-Alvira et al. time). Indeed, telomere shortening and accumulation of short telomeres over time has been proposed to be predictive of mortality in birds and mammals (37) (38) (39) .
CONCLUSIONS
The results of our cross-sectional study of middle- In a cross-sectional study, different vascular territories were analyzed by 2-dimensional and 3-dimensional ultrasound to quantify subclinical atherosclerosis burden and examine possible associations with mean telomere length and short telomere load in peripheral blood leukocytes examined by high-throughput quantitative fluorescence in situ hybridization.
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